These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22932005)

  • 1. Trends in meningococcal disease in the United States military, 1971-2010.
    Broderick MP; Faix DJ; Hansen CJ; Blair PJ
    Emerg Infect Dis; 2012 Sep; 18(9):1430-7. PubMed ID: 22932005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal polysaccharide vaccination of military recruits in Israel: preliminary assessment of vaccine effect.
    Mimouni D; Gdalevich M; Mandel Y; Haim M; Ashkenazi I; Shemer J; Block C
    Scand J Infect Dis; 1998; 30(3):263-4. PubMed ID: 9790134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.
    Brundage JF; Ryan MA; Feighner BH; Erdtmann FJ
    Clin Infect Dis; 2002 Dec; 35(11):1376-81. PubMed ID: 12439801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States.
    Mbaeyi S; Pondo T; Blain A; Yankey D; Potts C; Cohn A; Hariri S; Shang N; MacNeil JR
    JAMA Pediatr; 2020 Sep; 174(9):843-851. PubMed ID: 32687590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure.
    Wang X; Shutt KA; Vuong JT; Cohn A; MacNeil J; Schmink S; Plikaytis B; Messonnier NE; Harrison LH; Clark TA; Mayer LW
    J Infect Dis; 2015 Jun; 211(12):1887-94. PubMed ID: 25556253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Epidemiology and Trends in Meningococcal Disease-United States, 1996-2015.
    MacNeil JR; Blain AE; Wang X; Cohn AC
    Clin Infect Dis; 2018 Apr; 66(8):1276-1281. PubMed ID: 29126310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease.
    Dull PM; McIntosh ED
    Vaccine; 2012 May; 30 Suppl 2():B18-25. PubMed ID: 22607895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal disease in US military personnel before and after adoption of conjugate vaccine.
    Broderick MP; Phillips C; Faix D
    Emerg Infect Dis; 2015 Feb; 21(2):377-9. PubMed ID: 25625525
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of meningococcal vaccine and barriers to vaccination.
    Rosenstein N; Levine O; Taylor JP; Evans D; Plikaytis BD; Wenger JD; Perkins BA
    JAMA; 1998 Feb; 279(6):435-9. PubMed ID: 9466635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal disease and vaccination in North America.
    Pollard AJ; Scheifele D
    J Paediatr Child Health; 2001 Oct; 37(5):S20-7. PubMed ID: 11885732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.
    Jounio U; Saukkoriipi A; Bratcher HB; Bloigu A; Juvonen R; Silvennoinen-Kassinen S; Peitso A; Harju T; Vainio O; Kuusi M; Maiden MC; Leinonen M; Käyhty H; Toropainen M
    J Clin Microbiol; 2012 Feb; 50(2):264-73. PubMed ID: 22135261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel.
    Patel M; Romero-Steiner S; Broderick MP; Thomas CG; Plikaytis BD; Schmidt DS; Johnson SE; Milton AS; Carlone GM; Clark TA; Messonnier NE; Cohn AC; Faix DJ
    Vaccine; 2014 Jun; 32(30):3805-9. PubMed ID: 24837781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults.
    Pace D
    Future Microbiol; 2010 Nov; 5(11):1629-40. PubMed ID: 21133685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid serogroup identification of Neisseria meningitidis by using antiserum agar: Prevalence of serotypes in a disease-free military population.
    Craven DE; Frasch CE; Mocca LF; Rose FB; Gonzalez R
    J Clin Microbiol; 1979 Sep; 10(3):302-7. PubMed ID: 114532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serogroup Y meningococcal disease--Illinois, Connecticut, and selected areas, United States, 1989-1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(46):1010-3. PubMed ID: 8965799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010.
    Sáfadi MA; Carvalhanas TR; Paula de Lemos A; Gorla MC; Salgado M; Fukasawa LO; Gonçalves MG; Higa F; Brandileone MC; Sacchi CT; Ribeiro AF; Sato HK; Bricks LF; Cassio de Moraes J
    Emerg Infect Dis; 2014 May; 20(5):806-11. PubMed ID: 24751156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serogroup A, C, W, and Y meningococcal disease in persons previously vaccinated with a serogroup ACWY meningococcal vaccine - United States, 2014-2018.
    Blain AE; Reese HE; Marjuki H; Topaz N; Mbaeyi S; McNamara LA
    Vaccine; 2021 Dec; 39(52):7541-7544. PubMed ID: 34802785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.
    Maiden MC; Ibarz-Pavón AB; Urwin R; Gray SJ; Andrews NJ; Clarke SC; Walker AM; Evans MR; Kroll JS; Neal KR; Ala'aldeen DA; Crook DW; Cann K; Harrison S; Cunningham R; Baxter D; Kaczmarski E; Maclennan J; Cameron JC; Stuart JM
    J Infect Dis; 2008 Mar; 197(5):737-43. PubMed ID: 18271745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of a single dose of the quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, in the Korean Armed Forces.
    Im JH; Woo H; Ha BM; Lee JS; Chung MH; Jung J
    Vaccine; 2020 Jan; 38(4):730-732. PubMed ID: 31787413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.